• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term medical management of the liver transplant recipient: what the primary care physician needs to know.肝移植受者的长期医学管理:初级保健医生需要了解的内容。
Mayo Clin Proc. 2012 Aug;87(8):779-90. doi: 10.1016/j.mayocp.2012.02.021. Epub 2012 Jul 3.
2
[Hyperuricemia and uro-nephrological disorders].[高尿酸血症与泌尿-肾脏疾病]
Presse Med. 2011 Sep;40(9 Pt 1):865-8. doi: 10.1016/j.lpm.2011.05.006. Epub 2011 Jun 17.
3
Long-term management of the kidney transplant recipient.肾移植受者的长期管理。
Blood Purif. 2012;33(1-3):205-11. doi: 10.1159/000334158. Epub 2012 Jan 20.
4
Care of the liver transplant patient.肝移植患者的护理。
Can J Gastroenterol Hepatol. 2014 Apr;28(4):213-9. doi: 10.1155/2014/453875.
5
Medical management of the liver transplant recipient.肝移植受者的医学管理。
Clin Liver Dis. 2011 Nov;15(4):821-43. doi: 10.1016/j.cld.2011.08.007.
6
Long-term care of the liver allograft recipient.肝脏移植受者的长期护理
Semin Liver Dis. 2009 Feb;29(1):102-20. doi: 10.1055/s-0029-1192059. Epub 2009 Feb 23.
7
Managing kidney transplant recipients in primary care.在基层医疗中管理肾移植受者。
JAAPA. 2017 Jun;30(6):26-33. doi: 10.1097/01.JAA.0000513351.60771.d1.
8
Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors.肝移植:免疫抑制、肾功能不全及心血管危险因素的作用
Minerva Chir. 2012 Feb;67(1):1-13.
9
Management of hyperuricemia and gout in CKD.慢性肾脏病中高尿酸血症和痛风的管理
Am J Kidney Dis. 2008 Nov;52(5):994-1009. doi: 10.1053/j.ajkd.2008.07.035.
10
Long-term care of the liver transplant recipient.肝移植受者的长期护理
Clin Liver Dis. 2007 May;11(2):397-416. doi: 10.1016/j.cld.2007.04.003.

引用本文的文献

1
Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study.肝移植中的维持免疫抑制治疗:来自 CESIT 研究的结果,一项意大利回顾性队列研究。
BMJ Open. 2024 Nov 12;14(11):e087373. doi: 10.1136/bmjopen-2024-087373.
2
Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients.代谢功能障碍相关脂肪性肝炎肝移植受者的初级保健利用、预防性筛查和代谢综合征控制。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241247974. doi: 10.1177/21501319241247974.
3
Use of machine learning models for the prognostication of liver transplantation: A systematic review.机器学习模型在肝移植预后评估中的应用:一项系统综述。
World J Transplant. 2024 Mar 18;14(1):88891. doi: 10.5500/wjt.v14.i1.88891.
4
The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma.mTOR 抑制剂在肝癌肝移植术后的作用。
Curr Oncol. 2023 Jun 9;30(6):5574-5592. doi: 10.3390/curroncol30060421.
5
Immunosuppressive Drugs in Liver Transplant: An Insight.肝移植中的免疫抑制药物:深入剖析
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1557-1571. doi: 10.1016/j.jceh.2022.06.007. Epub 2022 Jun 22.
6
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases.同种异体家族性高胆固醇血症的肝移植是否具有治疗效果?全球九例病例综述。
Adv Ther. 2022 Jun;39(6):3042-3057. doi: 10.1007/s12325-022-02131-3. Epub 2022 Apr 26.
7
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment.肝移植后成功的重新定义:从死亡率到功能和实现。
Liver Transpl. 2022 Feb;28(2):304-313. doi: 10.1002/lt.26325. Epub 2021 Dec 27.
8
Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany.德国肝移植受者移植后护理的当前挑战
J Clin Med. 2020 Nov 5;9(11):3570. doi: 10.3390/jcm9113570.
9
Medical management of metabolic and cardiovascular complications after liver transplantation.肝移植后代谢和心血管并发症的医学管理。
World J Gastroenterol. 2020 May 14;26(18):2138-2154. doi: 10.3748/wjg.v26.i18.2138.
10
Treatment of Dyslipidemia in Common Liver Diseases.常见肝脏疾病中的血脂异常治疗
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1189-1196. doi: 10.1016/j.cgh.2018.04.023. Epub 2018 Apr 21.

本文引用的文献

1
Approach to the patient with new-onset diabetes after transplant (NODAT).移植后新发糖尿病(NODAT)患者的处理方法。
J Clin Endocrinol Metab. 2011 Nov;96(11):3289-97. doi: 10.1210/jc.2011-0657.
2
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.荟萃分析:吡格列酮可改善非酒精性脂肪性肝炎患者的肝脏组织学和纤维化。
Aliment Pharmacol Ther. 2012 Jan;35(1):66-75. doi: 10.1111/j.1365-2036.2011.04912.x. Epub 2011 Nov 4.
3
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis.基于西罗莫司的免疫抑制在肝癌肝移植中的应用:一项荟萃分析。
Liver Transpl. 2012 Jan;18(1):62-9. doi: 10.1002/lt.22441.
4
Posttransplant lymphoproliferative disease following liver transplantation.肝移植后发生的移植后淋巴组织增生性疾病。
Curr Opin Organ Transplant. 2011 Jun;16(3):274-80. doi: 10.1097/MOT.0b013e3283465715.
5
Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎患者行肝移植术后结直肠肿瘤的发生风险。
Inflamm Bowel Dis. 2012 Feb;18(2):269-74. doi: 10.1002/ibd.21692. Epub 2011 Mar 18.
6
Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.肝移植受者的代谢综合征:患病率、危险因素及与心血管事件的关系。
Liver Transpl. 2011 Jan;17(1):15-22. doi: 10.1002/lt.22198.
7
Standards of medical care in diabetes--2011.《糖尿病医疗护理标准——2011 年》
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc11-S011.
8
Liver transplantation for alcoholic liver disease.肝移植治疗酒精性肝病。
World J Gastroenterol. 2010 Sep 21;16(35):4377-93. doi: 10.3748/wjg.v16.i35.4377.
9
Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis.肾不足的肝移植受者使用西罗莫司:系统评价和荟萃分析。
Hepatology. 2010 Oct;52(4):1360-70. doi: 10.1002/hep.23835.
10
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.肝移植受者新发恶性肿瘤的风险因素和发生率:系统评价。
Liver Int. 2010 Oct;30(9):1247-58. doi: 10.1111/j.1478-3231.2010.02303.x.

肝移植受者的长期医学管理:初级保健医生需要了解的内容。

Long-term medical management of the liver transplant recipient: what the primary care physician needs to know.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Mayo Clin Proc. 2012 Aug;87(8):779-90. doi: 10.1016/j.mayocp.2012.02.021. Epub 2012 Jul 3.

DOI:10.1016/j.mayocp.2012.02.021
PMID:22763347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3498400/
Abstract

Recognition, management, and prevention of medical complications and comorbidities after liver transplant is the key to improved long-term outcomes. Beyond allograft-related complications, metabolic syndrome, cardiovascular disease, renal dysfunction, and malignancies are leading causes of morbidity and mortality in this patient population. Primary care physicians have an important role in improving outcomes of liver transplant recipients and are increasingly relied on for managing these complex patients. This review serves to assist the primary care physician in the long-term management issues of liver transplant recipients.

摘要

肝移植后对医学并发症和合并症的识别、管理和预防是改善长期预后的关键。除了移植物相关并发症外,代谢综合征、心血管疾病、肾功能障碍和恶性肿瘤是该患者人群发病率和死亡率的主要原因。初级保健医生在改善肝移植受者的预后方面发挥着重要作用,并且越来越依赖他们来管理这些复杂的患者。本文旨在帮助初级保健医生解决肝移植受者的长期管理问题。